Hyperthermia and ablation system developer BSD Medical said the University of Utah School of Medicine has launched a study that will evaluate the firm's MicroThermX microwave ablation system for treating liver tumors.
The single-arm trial will include 20 patients and evaluate both cirrhotic and noncirrhotic liver tissue. Principal investigator Dr. Ryan O'Hara and colleagues plan to clinically evaluate the size of the ablation zones produced in liver tissue by the Synchronous Wave Alignment technology used in MicroThermX, according to BSD.
